| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥5.52B | +28.0% |
| Gross profit | ¥1.90B | — |
| Operating income | ¥1.50B | — |
| Net income | ¥1.29B | +39.9% |
| Gross margin | 34.5% | Net margin 23.3% |
| Revenue Q/Q | +6.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥3.62B | 65.5% |
| R&D | ¥0.15B | 2.8% |
| SG&A | ¥0.18B | 3.3% |
| Tax & other | ¥0.21B | 3.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
温氏股份 ・ 新易盛 ・ 亿联网络 ・ 圣邦股份 ・ 宁德时代 ・ 迈瑞医疗 ・ 指南针 ・ 新产业 ・ 安克创新 ・ 爱美客 ・ 金龙鱼 ・ 锐捷网络
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies